ALX Oncology Holdings Inc.
ALXO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $22,185 | $33,243 | $88,180 |
| - Cash | $23,442 | $19,302 | $20,614 | $17,567 |
| + Debt | $0 | $16,182 | $9,971 | $9,904 |
| Enterprise Value | – | $19,065 | $22,600 | $80,517 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$21,583 | -$25,353 | -$30,137 | -$28,522 |
| % Margin | – | – | – | – |
| Net Income | -$22,144 | -$25,949 | -$30,754 | -$29,163 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.41 | -0.49 | -0.58 | -0.55 |
| % Growth | 16.3% | 15.5% | -5.5% | – |
| Operating Cash Flow | -$17,093 | -$23,406 | -$24,663 | -$32,046 |
| Capital Expenditures | -$56 | -$47 | -$60 | -$60 |
| Free Cash Flow | -$17,149 | -$23,453 | -$24,723 | -$32,106 |